case_images: PMC6965312_01
case_images: Chest X Ray at PICU admission (48 h after the ingestion).
case_images: fped-07-00542-g0001.jpg
case_images: PMC6965312_01_fped-07-00542-g0001.jpg
case_images: F1
case_images: Initial investigations showed diffuse, bilateral pulmonary opacities on chest X-ray (Figure 1), ratio of partial pressure of oxygen in arterial blood/fractional oxygen concentration (PaO2/FiO2) of 65, and oxygenation index (OI) of 41.
case_images: Trend of Coagulation markers (Day 1-5).
case_images: fped-07-00542-g0002.jpg
case_images: PMC6965312_01_fped-07-00542-g0002.jpg
case_images: F2
case_images: Both hemodynamic status and sepsis markers improved over next 24 h (Figure 2).
case_images: Trend of liver function markers (Day 1-5).
case_images: fped-07-00542-g0003.jpg
case_images: PMC6965312_01_fped-07-00542-g0003.jpg
case_images: F3
case_images: Transaminase (ALT) and Aspartate Transaminase (AST) of >7,000 and 4,320 IU/L, respectively, along with periportal hypoechogenicity on ultrasound (Figure 3). These resolved gradually over the first 6 days of admission.
case_images: Trend of infection markers (Day 1-5).
case_images: fped-07-00542-g0004.jpg
case_images: PMC6965312_01_fped-07-00542-g0004.jpg
case_images: F4
case_images: This was treated with heparin infusion, glyceryl trinitrate patches, and eventually debridement (Figure 4).